Abstract:Free fatty acid (FFA)-induced hepatic lipotoxicity plays a pivotal role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Inhibition of FFA-associated hepatic toxicity represents a potential therapeutic strategy. Recently, it was reported that FFA-induced hepatic injury is closely linked to the ER stress response and autophagy activities. Glycyrrhizin (GL), the major bioactive component of licorice root extract, is a traditional Chinese medicine and has been used to treat hepatitis to reduce liver inflammation and hepatic injury for many years. However, the underlying cellular mechanism responsible for its positive clinical effects has not been elucidated. 18β-glycyrrhetinic acid (GA) is the biologically activemetabolite of GL. We have previous reported that GA prevents FFA-induced hepatic lipotoxicity by stabilization of lysosomal membrane and inhibition of cathepsin B expression and enzyme activity in hepatocytes. Our preliminary studies indicate that palmitic acid (PA) dose-dependently activates the ER stress response in hepatocytes. The aim of the current study was to determine whether GA prevents PA-induced hepatic injury through modulating ER stress response and autophagy activities in hepatocytes. Methods: Rat primary hepatocytes were treated with 0.25 mM PA in the presence of GA (0-10 μM) for various time periods. The intracellular lipid accumulation was detected by nile red staining. The expression levels of ER stress marker genes (GRP78, CHOP, XBP-1, ATF-4) were determined by real-time RTPCR and Western blot analysis. Activation of autophagy was determined by measuring the conversion of microtubule-associated protein 1 light chain 3 (LC3) without or with 2 htreatment of lysosomal inhibitors using Western blot analysis. The mRNA expression levels of key genes involved in hepatic lipid metabolism were assessed using real-time RT-PCR. Lentiviral shRNA was used to knock down GRP78 expression. Results: In rat primary hepatocytes, GA increased GRP78 mRNA and protein levels by 53% and 28%, respectively, over control cells. In addition, GA induced autophagy activities and reduced intracellular lipid accumulation. Furthermore, GA significantly reduced the expression of SREBP-1/ SREBP-2-target genes, i.e. fatty acid synthase (FAS), stearoyl-CoA desaturase 1 (SCD-1), 3hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoAR), and LDL receptor (LDL-R). GAmediated protective effect against PA-induced hepatic lipotoxicity was eliminated by downregulation of GRP78 expression using lentiviral shRNA. Conclusion: FFA-induced hepatic lipotoxicity is strongly related to the activation of hepatic ER stress. Regulation of GRP78 expression may represent an important mechanism by which GA prevents PA-induced hepatic lipotoxicity.

Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway

Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2

18β-Glycyrrhetinic Acid Ameliorates Acute Propionibacterium acnes-induced Liver Injury through Inhibition of Macrophage Inflammatory Protein-1α

Glycyrrhizic Acid Inhibits Core Fucosylation Modification Modulated EMT and Attenuates Bleomycin-Induced Pulmonary Fibrosis

18β-glycyrrhetinic acid ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibiting TGF-β1/JAK2/STAT3 signaling axis

Glycyrrhizic Acid Improving the Liver Protective Effect by Restoring the Composition of Lactobacillus

Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling

Prevention of Free Fatty Acid-Induced Hepatic Lipotoxicity by 18Beta-Glycyrrhetinic Acid Through Lysosomal and Mitochondrial Pathways.

Glycyrrhizic acid restores the downregulated hepatic ACE2 signaling in the attenuation of mouse steatohepatitis

Transcriptome and Lipid Metabolomics-Based Discovery: Glycyrrhizic Acid Alleviates Tripterygium Glycoside Tablet-Induced Acute Liver Injury by Regulating the Activities of CYP and the Metabolism of Phosphoglycerides

Prevention of Free Fatty Acids/high Fat Diet‐induced Hepatic Lipotoxicity by 18β Glycyrrhetinic Acid

Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the Mir-21-regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo

695 18ß-Glycyrrhetinic Acid Prevents Free Fatty Acid-Induced Hepatic Lipotoxicity by Upregulating GRP78 Expression

18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs

Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis

Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms

Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence

Glycyrrhetinic Acid Pretreatment Attenuates Liver Ischemia/reperfusion Injury Via Inhibiting TLR4 Signaling Cascade in Mice.

Gooseberry Anthocyanins Protect Mice Hepatic Fibrosis by Inhibiting TGF-β/Smad Pathway

Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.